
	Three Months Ended September 30,				Nine Months Ended September 30,
(AMOUNTS IN MILLIONS EXCEPT PER SHARE AMOUNTS)	2026		2025		2026		2025
Net Income


Net (loss) income from continuing operations	$	(127)	$	99	$	61	$	717
Net income (loss) from discontinued operations	72		(58)		105		(1,094)
Net (loss) income	(55)		41		166		(377)
Net income attributable to non-controlling interests from continuing operations	—		—		1		1
Net income attributable to non-controlling interests from discontinued operations	—		1		1		1
Net (loss) income attributable to IFF shareholders	$	(55)	$	40	$	164	$	(379)

Shares
Average number of shares outstanding - basic	253		256		254		255
Adjustment for assumed dilution:
Stock options and restricted stock awards	—		1		1		1

Weighted average shares assuming dilution (diluted)	253		257		255		256






Net (Loss) Income per Share
Continuing operations	$	(0.50)	$	0.39	$	0.24	$	2.81
Discontinued operations	0.28		(0.23)		0.41		(4.29)
Net (loss) income per share - basic	$	(0.22)	$	0.16	$	0.65	$	(1.48)

Continuing operations	$	(0.50)	$	0.39	$	0.23	$	2.80
Discontinued operations	0.28		(0.23)		0.41		(4.28)
Net (loss) income per share - diluted	$	(0.22)	$	0.16	$	0.64	$	(1.48)

The Company declared a quarterly dividend to its shareholders of $0.40 per share for each of the three months ended September 30, 2026 and 2025. For each of the nine months ended September 30, 2026 and 2025, the Company declared quarterly dividends to its shareholders totaling $1.20.

For the three and nine months ended September 30, 2026 and September 30, 2025, there were approximately 0.2 million and 0.3 million share equivalents, respectively, that had an anti-dilutive effect and therefore were excluded from the computation of diluted net (loss) income per share.

On August 4, 2026, the Company announced that its Board of Directors authorized an enhanced share repurchase authorization with a total value of $2.5 billion; this amount included approximately $400 million remaining on its prior authorization. Under the program, the Board of Directors authorized an accelerated share repurchase (“ASR”) of $500 million.

On August 21, 2026, the Company entered into an ASR agreement with Wells Fargo Bank, National Association to repurchase the Company’s shares under a forward share repurchase transaction. During the three months ended September 30, 2026, the Company received approximately 4.8 million shares related to the ASR Agreement and recorded $500 million to treasury stock for the cost of shares received as well as associated fees and excise tax. On November 3, 2026, upon final settlement of the ASR agreement, the Company received approximately 1 million additional shares.

The remaining unused amount of the share repurchase authorization is expected to be executed following the closing of the Food Ingredients disposal group divestiture, with an expected completion of the program by the end of 2027. The Board will review the share repurchase program periodically and may authorize adjustments of its term and size. The Company plans to fund repurchases from cash provided by operating activities, short-term debt and net cash proceeds provided by the divestiture of the Food Ingredients disposal group.